Modeling the response of the asthmatic airways to adenosine: Mechanisms and receptors

Drug Development Research

Volumn 59, Issue 1, 2003, Pages 23-29

  Fozard, John R ^a   Tigani, Bruno ^a   Wolber, Cedric ^a   Williams, Iwan ^a   Mazzoni, Lazzaro ^a   Hannon, Jason P ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adenosine receptors; Airway hyperresponsiveness; Allergen challenge; Asthma; Brown Norway rats; Mast cell activation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; HISTAMINE; IMMUNOGLOBULIN E; KETANSERIN; METHYSERGIDE; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; OVALBUMIN; SEROTONIN; THEOPHYLLINE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANTAGONISM; HISTAMINE RELEASE; MAST CELL; NONHUMAN; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; TACHYPHYLAXIS;

EID: 0038651095     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10195     Document Type: Conference Paper

References (42)

1. 2 receptors in serotonin-induced contractions of non-vascular smooth muscle. J Pharmacol Exp Ther 232:770-774.
2. Cushley MJ, Tattersfield AE, Holgate ST. 1983. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15:161-165.
3. 1. Am J Respir Crit Care Med 165:327-331.
4. Elwood W, Lötval JO, Barnes PJ, Fan Chung K. 1991. Characterisation of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitised Brown Norway rats. J Allergy Clin Immunol 88:951-960.
5. Elwood W, Sakamoto T, Barnes PJ, Fan Chung K. 1993. Allergen-induced airway hyperresponsiveness in Brown Norway rat: role of parasympathetic mechanisms. J Appl Physiol 75:279-284.
6. Elwood W, Lötval JO, Barnes PJ, Fan Chung K. 1992. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown Norway rats. Am Rev Resp Dis 145:1289-1294.
7. 2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148-153.
8. Fozard JR, Hannon JP. 1999. Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm Pharmacol Ther 12:111-114.
9. Fozard JR, Hannon JP. 2000. Species differences in adenosine induced bronchoconstrictor responses. Clin Exp Allergy 30:1213-1220.
10. Haczku A, Macary P, Haddad EB, Huang TJ, Kemeny DM, Moqbel R, Fan Chung K. 1996. Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-gamma in ovalbumin-exposed sensitised brown-Norway rats. Immunology 88:247-251.
11. Haczku A, Macary P, Huang TJ, Tsukagoshi H, Barnes PJ, Kay AB, Kemeny M, Fan Chung K, Moqbel R. 1997. Adoptive transfer of allergen-specific CD4+ T-cells induces airway inflammation and hyperresponsiveness in brown Norway rats. Immunology 91:176-185.
12. Hannon JP. 2000. Mechanisms of airway hyperreactivity to adenosine, induced by allergen challenge, in the actively sensitised brown Norway rat. PhD Thesis, University of London.
13. 3 receptor-mediated hypotension in the anaesthetised rat. Br J Pharmacol 115:945-952.
14. Hannon JP, Tigani B, Williams, Mazzoni L, Fozard JR. 2001. Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitised Brown Norway rats. Br J Pharmacol 132:1509-1523.
15. Hannon JP, Tigani B, Wolber C, Williams I, Mazzoni L, Howes C, Fozard JR. 2002. Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitised brown Norway rats. Br J Pharmacol 135:685-696.
16. Holgate ST. 2002a. Adenosine provocation: a new test for allergic-type airway inflammation. Am J Respir Crit Care Med 165:317-319.
17. Holgate ST. 2002b. Adenosine: a key effector molecule of asthma or just another mediator? Am J Physiol Lung Cell Mol Physiol 282:L167-L168.
18. 2B adenosine receptors. Drug Dev Res 47:45-53.
19. Marquardt DL. 1997. Adenosine. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, editors. Asthma. Philadelphia, New York: Lippincott-Raven. p 585-591.
20. Meade CJ, Dumont I, Worrall L. 2001. Why do asthmatic subjects respond so strongly to inhaled adenosine? Life Sci 69:1225-1240.
21. 4. J Appl Physiol 80:583-590.
22. Pauwels R, Bazin H, Platteau B, Van Der Straeten M. 1979. The influence of antigen dose on IgE production in different rat strains. Immunology 36:151-157.
23. Pauvvels R, Van Der Straeten M, Weyne J, Bazin H. 1985. Genetic factor in non-specific bronchial reactivity in rats. Eur J Respir Dis 66:98-104.
24. Peers SH, Duncan GS, Flower RJ. 1993. Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroid. Agents and Actions 39:174-181.
25. Phillips GD, Holgate ST. 1989. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in non-atopic asthma. Am Rev Resp Dis 139:463-469.
26. Phillips GD, Rafferty P, Beasley R, Holgate ST. 1987. The effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 42:939-945.
27. Phillips GD, Scott VL, Richards R, Holgate ST. 1989. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 2:210-217.
28. Polosa R. 2002. Adenosine receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 20:488-496.
29. Rafferty P, Beasley R, Southgate P, Holgate S. 1987. The role of histamine in allergen and adenosine-induced bronchoconstriction. Int Arch Allergy Appl Immunol 82:292-294.
30. Renzi PM, Olivenstein R, Martin JG. 1993. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Resp Dis 147:967-974.
31. Renzi PM, Al-Assaad AS, Yang JP, Yasruel Z, Hamid Q. 1996. Cytokine expression in the presence or absence of late airway responses after allergen challenge of sensitized animals. Am J Respir Cell Mol Biol 15:367-373.
32. Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST. 2002. Role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma. Thorax 57:323-327.
33. Sapienza S, Renzi PM, Martin JG. 1992. Effects of ketotifen on airway responses to allergen challenge in actively sensitised brown Norway rats. Agents Actions 37:238-244.
34. Schneider T, Issekutz AC. 1996. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a brown Norway rat model of allergic pulmonary inflammation. J Immunol Methods 198:1-14.
35. Tarayre JP, Aliaga M, Barbara M, Tisseyre N, Vieu S, Tisne- Versailles J. 1992. Model of bronchial allergic inflammation in the brown-Norway rat. Pharmacological modulation. Int J Immunopharmacol 14:847-855.
36. Tigani B, Hannon JP, Mazzoni L, Fozard JR. 2000. Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised brown Norway rats. Eur J Pharmacol 406:469-476.
37. Tigani B, Schaeublin E, Sugar R, Jackson AD, Fozard JR, Beckmann N. 2002. Pulmonary inflammation monitored non-invasively by MRI in freely breathing rats. Biochem Biophys Res Commun 292:216-221.
38. Underwood SL, Kemeny DM, Lee TH, Raeburn D, Karlsson JA. 1995. IgE production, antigen-induced airway inflammation and airway hyperreactivity in the brown Norway rat: the effects of ricin. Immunolology 85:256-261.
39. 20 of methacholine. Am J Respir Crit Care Med 164:1127-1132.
40. 20 of methacholine. Am J Respir Crit Care Med 1634:1546-1550.
41. 3 adenosine receptor. Mol Pharmacol 45:1101-1111.
42. Woolcock AJ. 1997. Definitions and clinical classification. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, editors. Asthma. Philadelphia, New York: Lippincott-Raven. p 27-32.